Table 4. White matter hyperintensities rated according to the ARWMC scale in DM1 and DM2 patients and control subjects at baseline (T1) and follow-up (T2).
| DM1 | DM2 | Control group | ||||
|---|---|---|---|---|---|---|
| T1 | T2 | T1 | T2 | T1 | T2 | |
| Total Score | 2.25 ± 3.00 | 2.44 ± 3.12 | 0.75 ± 1.53 | 0.88 ± 1.78 | 0.67 ± 0.91 | 0.94 ± 1.26 |
|
p-value (compared to controls) |
0.04* | 0.07 | 0.85 | 0.90 | ||
| Frontal subscore | 1.19 ± 1.60 | 1.25 ± 1.57 | 0.44 ± 0.85 | 0.50 ± 1.03 | 0.11 ± 0.47 | 0.17 ± 0.71 |
|
p-value (compared to controls) |
0.01* | 0.01* | 0.16 | 0.28 | ||
| Parieto-occipital subscore | 0.69 ± 1.30 | 0.75 ± 1.39 | 0.31 ± 0.87 | 0.38 ± 0.89 | 0.5 ± 0.71 | 0.67 ± 0.97 |
|
p-value (compared to controls) |
0.60 | 0.84 | 0.49 | 0.37 | ||
| Temporal subscore | 0.38 ± 1.09 | 0.38 ± 1.09 | 0 | 0 | 0 | 0 |
|
p-value (compared to controls) |
0.16 | 0.15 | ||||
| Infratentorial subscore | 0.00 | 0.06 ± 0.25 | 0.00 | 0.00 | 0.06 ± 0.24 | 0.11 ± 0.32 |
|
p-value (compared to controls) |
0.34 | 0.63 | 0.34 | 0.18 | ||
Given values are mean ± SD.
*p < 0.05; significant differences between patient and control groups.